{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:19:55Z","timestamp":1785363595183,"version":"3.55.0"},"reference-count":19,"publisher":"Galenos Yayinevi","issue":"0","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjps"],"published-print":{"date-parts":[[2023,12,25]]},"DOI":"10.4274\/tjps.galenos.2023.99148","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T07:06:40Z","timestamp":1693292800000},"page":"0-0","source":"Crossref","is-referenced-by-count":2,"title":["Characterization of forced degradation products of Netarsudil: Optimization and validation of stability-indicating RP-HPLC method for simultaneous quantification of process related impurities of Netarsudil"],"prefix":"10.4274","volume":"0","author":[{"given":"Bodasingi Sai","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jammu","family":"Harish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagya Kumar","family":"Tatavarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Eswarlal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkateswara Rao","family":"Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2023,12,25]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00769-006-0095-y","article-title":"The importance of impurity analysis in pharmaceutical products: an integrated approach","volume":"11","author":"Rahman","year":"2006","unstructured":"1. Rahman N, Azmi SNH, Fen Wu H. The importance of impurity analysis in pharmaceutical products: an integrated approach. Accred Qual Assur. 2006;11:69-74.","journal-title":"Accred Qual Assur"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.trac.2006.05.011","article-title":"The importance and the challenges of impurity profiling in modern pharmaceutical analysis","volume":"25","author":"G\u00f6r\u00f6g","year":"2006","unstructured":"2. G\u00f6r\u00f6g S. The importance and the challenges of impurity profiling in modern pharmaceutical analysis. TrAC Trends in Analytical Chemistry. 2006;25:755-757.","journal-title":"TrAC Trends in Analytical Chemistry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.2147\/OPTH.S154001","article-title":"Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date","volume":"12","author":"Dasso","year":"2018","unstructured":"3. Dasso L, Al-Khaled T, Sonty S, Aref AA. Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date. Clin Ophthalmol. 2018;12:1939-1944.","journal-title":"Clin Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejphar.2016.04.002","article-title":"Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes","volume":"787","author":"Li","year":"2016","unstructured":"4. Li G, Mukherjee D, Navarro I, Ashpole NE, Sherwood JM, Chang J, Overby DR, Yuan F, Gonzalez P, Kopczynski CC, Farsiu S, Stamer WD. Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes. Eur J Pharmacol. 2016;787:20-31.","journal-title":"Eur J Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajo.2019.01.003","article-title":"Long-term safety and ocular hypotensive efficacy evaluation of netarsudil ophthalmic solution: rho kinase elevated IOP treatment trial (ROCKET-2)","volume":"200","author":"MY","year":"2019","unstructured":"5. Kahook MY, Serle JB, Mah FS, Kim T, Raizman MB, Heah T, Ramirez-Davis N, Kopczynski CC, Usner DW, Novack GD; ROCKET-2 Study Group. Long-term safety and ocular hypotensive efficacy evaluation of netarsudil ophthalmic solution: rho kinase elevated IOP treatment trial (ROCKET-2). Am J Ophthalmol. 2019;200:130-137.","journal-title":"Am J Ophthalmol"},{"key":"ref5","unstructured":"6. Manoranjani M. Stability indicating assay method development and validation of netarsudil and latanoprost by RP-HPLC and its degradation. JETIR. 2019;6:825-832."},{"key":"ref6","unstructured":"7. Padmalatha K, Vijaya Durga D, Jagadeeswari N. A novel study on Rp-Hplc method development and validation for estimation of netarsudil and latanoprost in api and pharmaceutical dosage form. World J Pharm Res. 2021;10:1624-1633."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"308","DOI":"10.25258\/ijpqa.13.3.15","article-title":"Simultaneous estimation of netarsudil and latanoprost by stability indicating RP-HPLC-PDA in pure binary blend and their ophthalmic solution","volume":"13","author":"Kunala","year":"2022","unstructured":"8. Kunala A, Gummadi S. Simultaneous estimation of netarsudil and latanoprost by stability indicating RP-HPLC-PDA in pure binary blend and their ophthalmic solution. Int J Pharm Qual Assur. 2022;13:308-314.","journal-title":"Int J Pharm Qual Assur"},{"key":"ref8","unstructured":"9. Ramana LV, Narendra D, Lakshmi G. Method development and validation for simultaneous estimation of netarsudil & latanoprost by RP-HPLC method. Eur J Pharm Med Res. 2020;7:888-894."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.54037\/WJPS.2022.100111","article-title":"Development and Validation of stability indicating analytical method for the simultaneous estimation of netarsudil and latanoprost by RP-HPLC","volume":"10","author":"Sharanya P","year":"2022","unstructured":"10. Sai Sharanya P, Shoba Rani S. Development and Validation of stability indicating analytical method for the simultaneous estimation of netarsudil and latanoprost by RP-HPLC. World J Pharm Sci. 2022;10:104-112.","journal-title":"World J Pharm Sci"},{"key":"ref10","unstructured":"11. Dharmamoorthy G, Nataraj KS, Manjari Pawar AK. Development and validation of a stabilityindicating reverse-phase ultra-performance liquid chromatography method for the simultaneous determination of netarsudil and latanoprost in bulk and pharmaceutical formulation. Int J Green Pharm. 2020;14:179-185."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ajps.2022.11.001","article-title":"A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension","volume":"17","author":"Wang","year":"2022","unstructured":"12. Wang T, Zhang Y, Chi M, Zhao C, Cao L, Tian C, Kamei K, Zheng Y, Jiang Q. A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension. Asian J Pharm Sci. 2022;17:938-948.","journal-title":"Asian J Pharm Sci"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Kumar Raju SP, Reddy JR. Identification and characterization of novel hydrolytic degradation products of netarsudil by LC-Q-TOF-MS\/MS: In silico toxicity prediction. J Liq Chromatogr Relat Technol. 2022:45:1-9.","DOI":"10.1080\/10826076.2022.2089999"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1055\/s-0037-1610310","article-title":"Asymmetric Synthesis of Netarsudil: a new therapeutic for open-angle glaucoma","volume":"51","author":"MA","year":"2019","unstructured":"14. deLong MA, Sturdivant JM. Asymmetric Synthesis of Netarsudil: a new therapeutic for open-angle glaucoma. Synthesis. 2019;51:953-959.","journal-title":"Synthesis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.56808\/3027-7922.2392","article-title":"Intended high-performance liquid chromatography procedure for the quantification of norfloxacin and its potential impurities in active pharmaceutical ingredient and tablet dosage forms","volume":"42","author":"Kasimala","year":"2018","unstructured":"15. Kasimala BB, Mallu UR, Anna VR, Reddy LM. Intended high-performance liquid chromatography procedure for the quantification of norfloxacin and its potential impurities in active pharmaceutical ingredient and tablet dosage forms. Thai J Pharm Sci. 2018;42:27-36.","journal-title":"Thai J Pharm Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"457","DOI":"10.4274\/tjps.galenos.2018.34635","article-title":"Rapid stability indicating HPLC method for the analysis of leflunomide and its related impurities in bulk drug and formulations","volume":"16","author":"Mallu","year":"2019","unstructured":"16. Mallu UR, Anna VR, Kasimala BB. Rapid stability indicating HPLC method for the analysis of leflunomide and its related impurities in bulk drug and formulations. Turk J Pharm Sci. 2019;16:457-465.","journal-title":"Turk J Pharm Sci"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.53879\/id.55.12.11185","article-title":"Stability-indicating reversed-phase HPLC method for the separation and estimation of related impurities of cilnidipine in pharmaceutical formulations","volume":"55","author":"Kasimala","year":"2018","unstructured":"17. Kasimala BB, Anna VR, Reddy Mallu U. Stability-indicating reversed-phase HPLC method for the separation and estimation of related impurities of cilnidipine in pharmaceutical formulations. Indian Drugs. 2018;55:41-49.","journal-title":"Indian Drugs"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Sri Girija K, Kasimala BB, Anna VR. A new high-performance liquid chromatography method for the separation and simultaneous quantification of eptifibatide and its impurities in pharmaceutical injection formulation. Int J App Pharm. 2021;13;165-172.","DOI":"10.22159\/ijap.2021v13i2.39895"},{"key":"ref18","unstructured":"19. ICH validation of analytical procedures: text and methodology Q2(R1). Access Date: 27.10.1994."}],"container-title":["Turkish Journal of Pharmaceutical Sciences"],"original-title":[],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T11:55:02Z","timestamp":1721130902000},"score":1,"resource":{"primary":{"URL":"https:\/\/turkjps.org\/articles\/doi\/tjps.galenos.2023.99148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,25]]},"references-count":19,"journal-issue":{"issue":"0","published-online":{"date-parts":[[2023,12,25]]},"published-print":{"date-parts":[[2023,12,25]]}},"URL":"https:\/\/doi.org\/10.4274\/tjps.galenos.2023.99148","relation":{},"ISSN":["1304-530X","2148-6247"],"issn-type":[{"value":"1304-530X","type":"print"},{"value":"2148-6247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,25]]}}}